Ibandronate Sodium Catalog No.:M8787-2 2018 Aug 9

2018 Aug 9

Wnt-C59 was used to dose mice orally at 5-10 mg/kg once per day or 5 mg/kg twice per day

CAS Number: 135575-42-7

000-fold selective for 20 other human methyltransferases

7(8):1447-52

Ibandronate Sodium Catalog No.:M8787-2 2018 Aug 9Ibandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved